jueves, 17 de octubre de 2013

Neurodegeneration: Exploring Commonalities Across Diseases - Workshop Summary - Institute of Medicine

Neurodegeneration: Exploring Commonalities Across Diseases - Workshop Summary - Institute of Medicine

Neurodegeneration: Exploring Commonalities Across Diseases - Workshop Summary


Released: October 3, 2013
Note: Workshop Summaries contain the opinion of the presenters, but do NOT reflect the conclusions of the IOM. Learn more about the differences between Workshop Summaries and Consensus Reports.
Neurodegenerative diseases – such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) – are becoming increasingly more prevalent in the United States due to the aging population. Implications of these diseases are grave, both for individual and family quality of life and for healthcare costs. Recent findings have revealed potential commonalities and parallelisms in genetic and cellular mechanisms across neurodegenerative diseases. Enhanced sharing of research findings and collaboration across research communities could potentially help advance basic scientific knowledge about each disease and about neurodegeneration and neurodegenerative diseases in general. Furthermore, enhanced basic scientific understanding could facilitate therapeutics development for neurodegenerative disorders, including therapeutics that may address more than one neurodegenerative disease.
In 2012, the IOM Forum on Neuroscience and Nervous System Disorders hosted a workshop to explore commonalities across neurodegenerative diseases and to identify potential opportunities for collaboration across the respective research and development communities. This document summarizes the workshop.

No hay comentarios:

Publicar un comentario